Skip to main content
Erschienen in: Annals of Surgical Oncology 5/2015

01.05.2015 | Endocrine Tumors

A Risk Model to Determine Surgical Treatment in Patients with Thyroid Nodules with Indeterminate Cytology

verfasst von: Carlos Aitor Macias, MD, MPH, Dena Arumugam, MD, Renee L. Arlow, MD, Oliver S. Eng, MD, Shou-En Lu, PhD, Parisa Javidian, MD, Tomer Davidov, MD, FACS, Stanley Z. Trooskin, MD, FACS

Erschienen in: Annals of Surgical Oncology | Ausgabe 5/2015

Einloggen, um Zugang zu erhalten

Abstract

Background

Thyroid nodules are present in 19–67 % of the population and have a 5–10 % risk of malignancy. Fine needle aspiration biopsies are indeterminate in 20–30 % of patients, often necessitating thyroid surgery for diagnosis. We hypothesized that developing a risk model incorporating factors associated with malignancy could help predict the risk of malignancy in patients with indeterminate thyroid nodules.

Methods

We identified 151 patients with a cytologic diagnosis of follicular neoplasm (Bethesda IV) who progressed to surgery. We retrospectively analyzed demographic, clinical, sonographic, and cytological variables in relation to thyroid carcinoma.

Results

Of 151 patients, 51 (33.8 %) had a final diagnosis of thyroid carcinoma. Papillary carcinoma was diagnosed in 34 patients (66.7 %), follicular carcinoma in 15 (29.4 %), and Hürthle cell carcinoma in 2 (3.9 %). On univariate analysis, younger age, male gender, tobacco use, larger nodule size, and calcifications on ultrasound, nuclear atypia on cytology, and suspicious frozen section were associated with the presence of malignancy. When determining odds ratios, four factors were most predictive of malignancy: nodule calcification [odds ratio (OR) 6.37, 95 % confidence interval (CI) 1.62–25.1, p < 0.01] and nodule size (OR 1.75, 95 % CI 1.19–2.57, p < 0.01) on ultrasound, nuclear atypia on cytology (OR 4.91, 95 % CI 1.90–12.66, p < 0.01), and tobacco use (OR 4.59, 95 % CI 1.30–16.27, p < 0.02). A multivariable model based on these four factors resulted in a c-statistic of 0.82.

Conclusions

A multivariable model based on calcification, nodule size, nuclear atypia, and tobacco use may predict the risk of thyroid cancer requiring a total thyroidectomy in patients with thyroid nodules of indeterminate cytology.
Literatur
1.
Zurück zum Zitat American Thyroid Association Guidelines Taskforce on Thyroid N, Differentiated Thyroid C, Cooper DS, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19(11):1167–214.CrossRef American Thyroid Association Guidelines Taskforce on Thyroid N, Differentiated Thyroid C, Cooper DS, et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19(11):1167–214.CrossRef
2.
Zurück zum Zitat Gharib H, Goellner JR. Fine-needle aspiration biopsy of the thyroid: an appraisal. Ann Intern Med. 1993;118(4):282–9.CrossRefPubMed Gharib H, Goellner JR. Fine-needle aspiration biopsy of the thyroid: an appraisal. Ann Intern Med. 1993;118(4):282–9.CrossRefPubMed
3.
Zurück zum Zitat Davidov T, Trooskin SZ, Shanker BA, et al. Routine second-opinion cytopathology review of thyroid fine needle aspiration biopsies reduces diagnostic thyroidectomy. Surgery. 2010;148(6):1294–9; discussion 1299–301CrossRefPubMed Davidov T, Trooskin SZ, Shanker BA, et al. Routine second-opinion cytopathology review of thyroid fine needle aspiration biopsies reduces diagnostic thyroidectomy. Surgery. 2010;148(6):1294–9; discussion 1299–301CrossRefPubMed
4.
Zurück zum Zitat Chernyavsky VS, Shanker BA, Davidov T, et al. Is one benign fine needle aspiration enough? Ann Surg Oncol. 2012;19(5):1472–6.CrossRefPubMed Chernyavsky VS, Shanker BA, Davidov T, et al. Is one benign fine needle aspiration enough? Ann Surg Oncol. 2012;19(5):1472–6.CrossRefPubMed
5.
Zurück zum Zitat Nikiforov YE, Yip L, Nikiforova MN. New strategies in diagnosing cancer in thyroid nodules: impact of molecular markers. Clin Cancer Res. May 1 2013;19(9):2283–2288.CrossRefPubMed Nikiforov YE, Yip L, Nikiforova MN. New strategies in diagnosing cancer in thyroid nodules: impact of molecular markers. Clin Cancer Res. May 1 2013;19(9):2283–2288.CrossRefPubMed
6.
Zurück zum Zitat Alexander EK, Kennedy GC, Baloch ZW, et al. Preoperative diagnosis of benign thyroid nodules with indeterminate cytology. N Engl J Med. 2012;367(8):705–15.CrossRefPubMed Alexander EK, Kennedy GC, Baloch ZW, et al. Preoperative diagnosis of benign thyroid nodules with indeterminate cytology. N Engl J Med. 2012;367(8):705–15.CrossRefPubMed
7.
Zurück zum Zitat Kelman AS, Rathan A, Leibowitz J, Burstein DE, Haber RS. Thyroid cytology and the risk of malignancy in thyroid nodules: importance of nuclear atypia in indeterminate specimens. Thyroid. 2001;11(3):271–7.CrossRefPubMed Kelman AS, Rathan A, Leibowitz J, Burstein DE, Haber RS. Thyroid cytology and the risk of malignancy in thyroid nodules: importance of nuclear atypia in indeterminate specimens. Thyroid. 2001;11(3):271–7.CrossRefPubMed
8.
Zurück zum Zitat Tyler DS, Winchester DJ, Caraway NP, Hickey RC, Evans DB. Indeterminate fine-needle aspiration biopsy of the thyroid: identification of subgroups at high risk for invasive carcinoma. Surgery. 1994;116(6):1054–60.PubMed Tyler DS, Winchester DJ, Caraway NP, Hickey RC, Evans DB. Indeterminate fine-needle aspiration biopsy of the thyroid: identification of subgroups at high risk for invasive carcinoma. Surgery. 1994;116(6):1054–60.PubMed
9.
Zurück zum Zitat Baloch ZW, Fleisher S, LiVolsi VA, Gupta PK. Diagnosis of “follicular neoplasm”: a gray zone in thyroid fine-needle aspiration cytology. Diagn Cytopathol. 2002;26(1):41–4.CrossRefPubMed Baloch ZW, Fleisher S, LiVolsi VA, Gupta PK. Diagnosis of “follicular neoplasm”: a gray zone in thyroid fine-needle aspiration cytology. Diagn Cytopathol. 2002;26(1):41–4.CrossRefPubMed
10.
Zurück zum Zitat Goldstein RE, Netterville JL, Burkey B, Johnson JE. Implications of follicular neoplasms, atypia, and lesions suspicious for malignancy diagnosed by fine-needle aspiration of thyroid nodules. Ann Surg. 2002;235(5):656–62; discussion 662–4.CrossRefPubMedCentralPubMed Goldstein RE, Netterville JL, Burkey B, Johnson JE. Implications of follicular neoplasms, atypia, and lesions suspicious for malignancy diagnosed by fine-needle aspiration of thyroid nodules. Ann Surg. 2002;235(5):656–62; discussion 662–4.CrossRefPubMedCentralPubMed
11.
Zurück zum Zitat Koike E, Noguchi S, Yamashita H, et al. Ultrasonographic characteristics of thyroid nodules: prediction of malignancy. Arch Surg. 2001;136(3):334–7.CrossRefPubMed Koike E, Noguchi S, Yamashita H, et al. Ultrasonographic characteristics of thyroid nodules: prediction of malignancy. Arch Surg. 2001;136(3):334–7.CrossRefPubMed
12.
Zurück zum Zitat Raber W, Kaserer K, Niederle B, Vierhapper H. Risk factors for malignancy of thyroid nodules initially identified as follicular neoplasia by fine-needle aspiration: results of a prospective study of one hundred twenty patients. Thyroid. 2000;10(8):709–12.CrossRefPubMed Raber W, Kaserer K, Niederle B, Vierhapper H. Risk factors for malignancy of thyroid nodules initially identified as follicular neoplasia by fine-needle aspiration: results of a prospective study of one hundred twenty patients. Thyroid. 2000;10(8):709–12.CrossRefPubMed
13.
Zurück zum Zitat Lubitz CC, Faquin WC, Yang J, et al. Clinical and cytological features predictive of malignancy in thyroid follicular neoplasms. Thyroid. 2010;20(1):25–31.CrossRefPubMed Lubitz CC, Faquin WC, Yang J, et al. Clinical and cytological features predictive of malignancy in thyroid follicular neoplasms. Thyroid. 2010;20(1):25–31.CrossRefPubMed
14.
Zurück zum Zitat Hosmer DW, Lemeshow LS. Applied logistic regression. Hoboken: Wiley; 2000.CrossRef Hosmer DW, Lemeshow LS. Applied logistic regression. Hoboken: Wiley; 2000.CrossRef
15.
Zurück zum Zitat Efron B GG. A leisurely look at the bootstrap, the jackknife, and cross-validation. Am Stat. 1983;37(1):36–48. Efron B GG. A leisurely look at the bootstrap, the jackknife, and cross-validation. Am Stat. 1983;37(1):36–48.
16.
Zurück zum Zitat Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15(4):361–87.CrossRefPubMed Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15(4):361–87.CrossRefPubMed
17.
Zurück zum Zitat Cibas ES, Ali SZ. The Bethesda system for reporting thyroid cytopathology. Thyroid. 2009;19(11):1159–65.CrossRefPubMed Cibas ES, Ali SZ. The Bethesda system for reporting thyroid cytopathology. Thyroid. 2009;19(11):1159–65.CrossRefPubMed
18.
Zurück zum Zitat Broome JT, Solorzano CC. The impact of atypia/follicular lesion of undetermined significance on the rate of malignancy in thyroid fine-needle aspiration: evaluation of the Bethesda system for reporting thyroid cytopathology. Surgery. 2011;150(6):1234–41.CrossRefPubMed Broome JT, Solorzano CC. The impact of atypia/follicular lesion of undetermined significance on the rate of malignancy in thyroid fine-needle aspiration: evaluation of the Bethesda system for reporting thyroid cytopathology. Surgery. 2011;150(6):1234–41.CrossRefPubMed
19.
Zurück zum Zitat Krane JF, Vanderlaan PA, Faquin WC, Renshaw AA. The atypia of undetermined significance/follicular lesion of undetermined significance: malignant ratio: a proposed performance measure for reporting in The Bethesda system for thyroid cytopathology. Cancer Cytopathol. 2012;120(2):111–6.CrossRefPubMed Krane JF, Vanderlaan PA, Faquin WC, Renshaw AA. The atypia of undetermined significance/follicular lesion of undetermined significance: malignant ratio: a proposed performance measure for reporting in The Bethesda system for thyroid cytopathology. Cancer Cytopathol. 2012;120(2):111–6.CrossRefPubMed
20.
Zurück zum Zitat Grannan K, Snyder J, McDonough S, Engel A, Farnum J. Operative decision-making for follicular thyroid lesions: a community hospital system experience. Am Surg. 2011;77(4):443–6.PubMed Grannan K, Snyder J, McDonough S, Engel A, Farnum J. Operative decision-making for follicular thyroid lesions: a community hospital system experience. Am Surg. 2011;77(4):443–6.PubMed
21.
Zurück zum Zitat Lumachi F, Borsato S, Tregnaghi A, et al. FNA cytology and frozen section examination in patients with follicular lesions of the thyroid gland. Anticancer Res. 2009;29(12):5255–7.PubMed Lumachi F, Borsato S, Tregnaghi A, et al. FNA cytology and frozen section examination in patients with follicular lesions of the thyroid gland. Anticancer Res. 2009;29(12):5255–7.PubMed
22.
Zurück zum Zitat Liu FH, Liou MJ, Hsueh C, Chao TC, Lin JD. Thyroid follicular neoplasm: analysis by fine needle aspiration cytology, frozen section, and histopathology. Diagn Cytopathol. 2010;38(11):801–5.CrossRefPubMed Liu FH, Liou MJ, Hsueh C, Chao TC, Lin JD. Thyroid follicular neoplasm: analysis by fine needle aspiration cytology, frozen section, and histopathology. Diagn Cytopathol. 2010;38(11):801–5.CrossRefPubMed
23.
Zurück zum Zitat Yoon JH, Kwak JY, Kim EK, et al. How to approach thyroid nodules with indeterminate cytology. Ann Surg Oncol. 2010;17(8):2147–55.CrossRefPubMed Yoon JH, Kwak JY, Kim EK, et al. How to approach thyroid nodules with indeterminate cytology. Ann Surg Oncol. 2010;17(8):2147–55.CrossRefPubMed
24.
Zurück zum Zitat Miller B, Burkey S, Lindberg G, Snyder WH 3rd, Nwariaku FE. Prevalence of malignancy within cytologically indeterminate thyroid nodules. Am J Surg. 2004;188(5):459–62.CrossRefPubMed Miller B, Burkey S, Lindberg G, Snyder WH 3rd, Nwariaku FE. Prevalence of malignancy within cytologically indeterminate thyroid nodules. Am J Surg. 2004;188(5):459–62.CrossRefPubMed
26.
Zurück zum Zitat Mack WJ, Preston-Martin S, Dal Maso L, et al. A pooled analysis of case-control studies of thyroid cancer: cigarette smoking and consumption of alcohol, coffee, and tea. Cancer Causes Control. 2003;14(8):773–85.CrossRefPubMed Mack WJ, Preston-Martin S, Dal Maso L, et al. A pooled analysis of case-control studies of thyroid cancer: cigarette smoking and consumption of alcohol, coffee, and tea. Cancer Causes Control. 2003;14(8):773–85.CrossRefPubMed
27.
Zurück zum Zitat Davidov T, Nagar M, Kierson M, et al. Carbonic anhydrase 4 and crystallin alpha-B immunoreactivity may distinguish benign from malignant thyroid nodules in patients with indeterminate thyroid cytology. J Surg Res. 2014;190(2):565–74. Davidov T, Nagar M, Kierson M, et al. Carbonic anhydrase 4 and crystallin alpha-B immunoreactivity may distinguish benign from malignant thyroid nodules in patients with indeterminate thyroid cytology. J Surg Res. 2014;190(2):565–74.
Metadaten
Titel
A Risk Model to Determine Surgical Treatment in Patients with Thyroid Nodules with Indeterminate Cytology
verfasst von
Carlos Aitor Macias, MD, MPH
Dena Arumugam, MD
Renee L. Arlow, MD
Oliver S. Eng, MD
Shou-En Lu, PhD
Parisa Javidian, MD
Tomer Davidov, MD, FACS
Stanley Z. Trooskin, MD, FACS
Publikationsdatum
01.05.2015
Verlag
Springer US
Erschienen in
Annals of Surgical Oncology / Ausgabe 5/2015
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-014-4190-8

Weitere Artikel der Ausgabe 5/2015

Annals of Surgical Oncology 5/2015 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.